Tuberculosis: An Overview of the Immunogenic Response, Disease Progression, and Medicinal Chemistry Efforts in the Last Decade toward the Development of Potential Drugs for Extensively Drug-Resistant Tuberculosis Strains

Design, synthesis, and biological evaluation of novel 4H-chromen-4-one derivatives as antituberculosis agents against multidrug-resistant tuberculosis

(2020) Wenting Zhao et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Treatment of Highly Drug-Resistant Pulmonary Tuberculosis

(2020) Francesca Conradie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Therapeutic Nanoparticles and Their Targeted Delivery Applications

(2020) Abuzer Alp Yetisgin et al.   MOLECULES

Structures of cell wall arabinosyltransferases with the anti-tuberculosis drug ethambutol

(2020) Lu Zhang et al.   SCIENCE

Discovery of a Conformationally Constrained Oxazolidinone with Improved Safety and Efficacy Profiles for the Treatment of Multidrug-Resistant Tuberculosis

(2020) Hongyi Zhao et al.   JOURNAL OF MEDICINAL CHEMISTRY

Highly Potent and Selective N-aryl Oxamic Acid Based Inhibitors for Mycobacterium tuberculosis Protein Tyrosine Phosphatase B (mPTPB)

(2020) Kasi Viswanatharaju Ruddraraju et al.   JOURNAL OF MEDICINAL CHEMISTRY

Structure of mycobacterial ATP synthase bound to the tuberculosis drug bedaquiline

(2020) Hui Guo et al.   NATURE

Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II

(2019) Wei Zhang et al.   JOURNAL OF MEDICINAL CHEMISTRY

In vitro activity of DNF-3 against drug resistant Mycobacterium tuberculosis

(2019) Md Imtiazul Islam et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Novel 1,3,4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis

(2019) Vitthal B Makane et al.   Future Medicinal Chemistry

Structure-based design, synthesis and biological evaluation of a newer series of pyrazolo[1,5-a]pyrimidine analogues as potential anti-tubercular agents

(2019) Palmi Modi et al.   BIOORGANIC CHEMISTRY

Structure of a bacterial ATP synthase

(2019) Hui Guo et al.   eLife

Design and Synthesis of 2-Amino-thiophene-proline-conjugates and Their Anti-tubercular Activity against Mycobacterium Tuberculosis H37Ra

(2019) Sachin B. Baravkar et al.   ChemistrySelect

Azaaurones as Potent Antimycobacterial Agents Active against MDR‐ and XDR‐TB

(2019) André Campaniço et al.   ChemMedChem

Exploiting chitosan and gold nanoparticles for antimycobacterial activity of in silico identified antimicrobial motif of human neutrophil peptide-1

(2019) Richa Sharma et al.   Scientific Reports

Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs

(2019) Jody E. Phelan et al.   Genome Medicine

Mycobacterium tuberculosis Metabolism

(2019) Gabriel T. Mashabela et al.   Microbiology Spectrum

The effects of diabetes on tuberculosis treatment outcomes: an updated systematic review and meta-analysis

(2019) P. Huangfu et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Epidemiology of tuberculous lymphadenitis in Denmark: A nationwide register-based study

(2019) Victor Dahl Mathiasen et al.   PLoS One

Spray-Dried, Nanoencapsulated, Multi-Drug Anti-Tuberculosis Therapy Aimed at Once Weekly Administration for the Duration of Treatment

(2019) Lonji Kalombo et al.   Nanomaterials

The Anti-Mycobacterial Activity Of Ag, ZnO, And Ag- ZnO Nanoparticles Against MDR- And XDR-Mycobacterium tuberculosis

(2019) Mohsen Heidary et al.   Infection and Drug Resistance

Comparison of in vitro activity and MIC distributions between the novel oxazolidinone delpazolid and linezolid against multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in China

(2018) Zhaojing Zong et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis

(2018) Wei Zhang et al.   JOURNAL OF MEDICINAL CHEMISTRY

Mycobacterium tuberculosis: Active disease and latent infection in a renal transplant cohort

(2018) Nastaran Rafiei et al.   NEPHROLOGY

Novel compounds targeting InhA for TB therapy

(2018) Manaf AlMatar et al.   Pharmacological Reports

Antimicrobial peptides as an alternative to anti-tuberculosis drugs

(2018) Manaf AlMatar et al.   PHARMACOLOGICAL RESEARCH

Ionophoric effects of the antitubercular drug bedaquiline

(2018) Kiel Hards et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mannose-capped lipoarabinomannan in Mycobacterium tuberculosis pathogenesis

(2018) Joanne Turner et al.   Pathogens and Disease

Efficient analoging around ethionamide to explore thioamides bioactivation pathways triggered by boosters in Mycobacterium tuberculosis

(2018) Marion Prieri et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Challenges of TB and HIV co-treatment

(2018) Jeffrey A. Tornheim et al.   Current Opinion in HIV and AIDS

Nano based drug delivery systems: recent developments and future prospects

(2018) Jayanta Kumar Patra et al.   JOURNAL OF NANOBIOTECHNOLOGY

Effect of Moxifloxacin plus Pretomanid against Mycobacterium tuberculosis in Log Phase, Acid Phase, and Nonreplicating-Persister Phase in an In Vitro Assay

(2018) Carolina de Miranda Silva et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

CitE Enzymes Are Essential for Mycobacterium tuberculosis to Establish Infection in Macrophages and Guinea Pigs

(2018) Garima Arora et al.   Frontiers in Cellular and Infection Microbiology

Pyrazolo[1,5-a]pyridine-3-carboxamide hybrids: Design, synthesis and evaluation of anti-tubercular activity

(2017) Xiaoyun Lu et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Drivers of Tuberculosis Transmission

(2017) Barun Mathema et al.   JOURNAL OF INFECTIOUS DISEASES

What We Know About Tuberculosis Transmission: An Overview

(2017) Gavin Churchyard et al.   JOURNAL OF INFECTIOUS DISEASES

Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis

(2017) Subramanyam J. Tantry et al.   JOURNAL OF MEDICINAL CHEMISTRY

Novel Anti-Tuberculosis Nanodelivery Formulation of Ethambutol with Graphene Oxide

(2017) Bullo Saifullah et al.   MOLECULES

Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance

(2017) Abigail L Manson et al.   NATURE GENETICS

Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection

(2017) Lucy C. K. Bell et al.   NATURE REVIEWS MICROBIOLOGY

Pulmonary Tuberculosis: Role of Radiology in Diagnosis and Management

(2017) Arun C. Nachiappan et al.   RADIOGRAPHICS

Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB?

(2017) Keertan Dheda et al.   RESPIROLOGY

GeneXpert technology. A breakthrough for the diagnosis of tuberculous pericarditis and pleuritis in less than 2 hours

(2017) Muhammad Saeed et al.   SAUDI MEDICAL JOURNAL

Atomic model for the dimeric FOregion of mitochondrial ATP synthase

(2017) Hui Guo et al.   SCIENCE

Reversion of antibiotic resistance inMycobacterium tuberculosisby spiroisoxazoline SMARt-420

(2017) Nicolas Blondiaux et al.   SCIENCE

Integrating Lung Physiology, Immunology, and Tuberculosis

(2017) Jordi B. Torrelles et al.   TRENDS IN MICROBIOLOGY

Benzylsulfanyl benzo-heterocycle amides and hydrazones as new agents against drug-susceptible and resistant Mycobacterium tuberculosis

(2017) Xiaoyun Lu et al.   MedChemComm

Targeting Energy Metabolism in Mycobacterium tuberculosis , a New Paradigm in Antimycobacterial Drug Discovery

(2017) Dirk Bald et al.   mBio

Discovery of Fluorine-Containing Benzoxazinyl-oxazolidinones for the Treatment of Multidrug Resistant Tuberculosis

(2017) Hongyi Zhao et al.   ACS Medicinal Chemistry Letters

Nanostructured lipid carriers for incorporation of copper(II) complexes to be used against Mycobacterium tuberculosis

(2017) Mariana Rillo Sato et al.   Drug Design Development and Therapy

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

(2017) Keertan Dheda et al.   Lancet Respiratory Medicine

Malnutrition: Modulator of Immune Responses in Tuberculosis

(2017) Padmapriyadarsini Chandrasekaran et al.   Frontiers in Immunology

Bolstering Immunity through Pattern Recognition Receptors: A Unique Approach to Control Tuberculosis

(2017) Susanta Pahari et al.   Frontiers in Immunology

What Have We Learnt about BCG Vaccination in the Last 20 Years?

(2017) Hazel M. Dockrell et al.   Frontiers in Immunology

Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis

(2017) Qianqian Liu et al.   Scientific Reports

Inhibiting mycobacterial tryptophan synthase by targeting the inter-subunit interface

(2017) Katherine A. Abrahams et al.   Scientific Reports

Targeting Antibiotic Resistance

(2016) Mathieu F. Chellat et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Antibiotic resistance mechanisms in M. tuberculosis: an update

(2016) Liem Nguyen   ARCHIVES OF TOXICOLOGY

Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents

(2016) N.C. Desai et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Antimicrobial peptides as novel anti-tuberculosis therapeutics

(2016) João P. Silva et al.   BIOTECHNOLOGY ADVANCES

Linezolid in the treatment of drug-resistant tuberculosis: the challenge of its narrow therapeutic index

(2016) Sean Wasserman et al.   Expert Review of Anti-Infective Therapy

A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India

(2016) Amita Jain et al.   INDIAN JOURNAL OF MEDICAL RESEARCH

Drug-Resistant Tuberculosis

(2016) Sebastian G. Kurz et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Delamanid in the treatment of multidrug-resistant tuberculosis

(2016) R. Gupta et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis

(2016) Galina Karabanovich et al.   JOURNAL OF MEDICINAL CHEMISTRY

Crystal structure and stability of gyrase–fluoroquinolone cleaved complexes fromMycobacterium tuberculosis

(2016) Tim R. Blower et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Alteration in the Gut Microbiota Provokes Susceptibility to Tuberculosis

(2016) Nargis Khan et al.   Frontiers in Immunology

Multi-drug delivery of tuberculosis drugs by π-back bonded gold nanoparticles with multiblock copolyesters

(2016) Mani Gajendiran et al.   Materials Research Express

Isoniazid metabolism and hepatotoxicity

(2016) Pengcheng Wang et al.   Acta Pharmaceutica Sinica B

Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis – a critical review

(2015) Jagdeep Singh et al.   DRUG DELIVERY

Towards tuberculosis elimination: an action framework for low-incidence countries

(2015) Knut Lönnroth et al.   EUROPEAN RESPIRATORY JOURNAL

Why healthcare workers are sick of TB

(2015) Arne von Delft et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Nosocomial transmission of multidrug-resistant tuberculosis

(2015) V. Crudu et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Accuracy of the Xpert® MTB/RIF assay for the diagnosis of extra-pulmonary tuberculosis in South Korea

(2015) Y. W. Kim et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015

(2015) Y. Zhang et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Identification of an anti-TB compound targeting the tyrosyl-tRNA synthetase

(2015) Ningyu Zhu et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Bactericidal mode of action of bedaquiline

(2015) K. Hards et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Rapid detection of Mycobacterium tuberculosis complex by real-time PCR in sputum samples and its use in the routine diagnosis in a reference laboratory

(2015) Juliana Maira Watanabe Pinhata et al.   JOURNAL OF MEDICAL MICROBIOLOGY

WHO's new End TB Strategy

(2015) Mukund Uplekar et al.   LANCET

Intrinsically disordered proteins in cellular signalling and regulation

(2015) Peter E. Wright et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review

(2015) Yoko V. Laurence et al.   PHARMACOECONOMICS

The diagnostic targeting of a carbohydrate virulence factor from M.Tuberculosis

(2015) Conrad E. Chan et al.   Scientific Reports

Tuberculosis Treatment and Drug Regimens

(2015) G. Sotgiu et al.   Cold Spring Harbor Perspectives in Medicine

Structure and conformational states of the bovine mitochondrial ATP synthase by cryo-EM

(2015) Anna Zhou et al.   eLife

Structure of the mycobacterial ATP synthase Fo rotor ring in complex with the anti-TB drug bedaquiline

(2015) L. Preiss et al.   Science Advances

High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses

(2014) A. Piubello et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux

(2014) Richard E Lee et al.   NATURE MEDICINE

P450-Mediated O-Demethylated Metabolite Is Responsible for Rat Hepatobiliary Toxicity of Pyridyltriazine-Containing PI3K Inhibitors

(2014) Raju Subramanian et al.   TOXICOLOGICAL SCIENCES

Triosephosphate Isomerase Is Dispensable In Vitro yet Essential for Mycobacterium tuberculosis To Establish Infection

(2014) C. Trujillo et al.   mBio

Mycobacterium tuberculosis Metabolism

(2014) D. F. Warner   Cold Spring Harbor Perspectives in Medicine

Tryptophan Biosynthesis Protects Mycobacteria from CD4 T-Cell-Mediated Killing

(2013) Yanjia J. Zhang et al.   CELL

Contact screening in tuberculosis: can we identify those with higher risk?: Table 1–

(2013) Maria Aurora Mendes et al.   EUROPEAN RESPIRATORY JOURNAL

Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis

(2013) N. Alsaad et al.   EUROPEAN RESPIRATORY JOURNAL

Fixed-dose combination antituberculosis therapy: a systematic review and meta-analysis

(2013) Amr S. Albanna et al.   EUROPEAN RESPIRATORY JOURNAL

Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis

(2013) M. McGrath et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis

(2013) Regina Wilson et al.   Nature Chemical Biology

Characterisation of ATP-Dependent Mur Ligases Involved in the Biogenesis of Cell Wall Peptidoglycan in Mycobacterium tuberculosis

(2013) Tulika Munshi et al.   PLoS One

Identification of a small molecule with activity against drug-resistant and persistent tuberculosis

(2013) F. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Macrophages in tuberculosis: friend or foe

(2013) Evelyn Guirado et al.   Seminars in Immunopathology

New fluoroquinolones active against fluoroquinolones-resistant Mycobacterium tuberculosis strains

(2013) Valentina Guerrini et al.   TUBERCULOSIS

Prevalence of Latent and Active Tuberculosis among Dairy Farm Workers Exposed to Cattle Infected by Mycobacterium bovis

(2013) Pedro Torres-Gonzalez et al.   PLoS Neglected Tropical Diseases

Targeted Intracellular Delivery of Antituberculosis Drugs to Mycobacterium tuberculosis-Infected Macrophages via Functionalized Mesoporous Silica Nanoparticles

(2012) Daniel L. Clemens et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antitubercular Activity of Disulfiram, an Antialcoholism Drug, against Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Isolates

(2012) Yasuhiro Horita et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Functional and Genetic Characterization of the Tap Efflux Pump in Mycobacterium bovis BCG

(2012) Santiago Ramón-García et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efflux Pumps of Mycobacterium tuberculosis Play a Significant Role in Antituberculosis Activity of Potential Drug Candidates

(2012) Meenakshi Balganesh et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Outwitting Evolution: Fighting Drug-Resistant TB, Malaria, and HIV

(2012) Daniel E. Goldberg et al.   CELL

Totally Drug-Resistant and Extremely Drug-Resistant Tuberculosis: The Same Disease?

(2012) G. B. Migliori et al.   CLINICAL INFECTIOUS DISEASES

Site of Extrapulmonary Tuberculosis is Associated with HIV Infection

(2012) Ira L. Leeds et al.   CLINICAL INFECTIOUS DISEASES

Drug Susceptibility Testing for Optimizing Tuberculosis Treatment

(2012) Sami O. Simons et al.   CURRENT PHARMACEUTICAL DESIGN

Contact investigation for tuberculosis: a systematic review and meta-analysis

(2012) G. J. Fox et al.   EUROPEAN RESPIRATORY JOURNAL

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

(2012) Vija Skripconoka et al.   EUROPEAN RESPIRATORY JOURNAL

Pre-XDR & XDR in MDR and Ofloxacin and Kanamycin resistance in non-MDR Mycobacterium tuberculosis isolates

(2012) Amita Jain et al.   TUBERCULOSIS

The role of dendritic cells inMycobacterium tuberculosisinfection

(2012) Adane Mihret   Virulence

Structural insights into RipC, a putative citrate lyase β subunit from aYersinia pestisvirulence operon

(2011) Rodrigo Torres et al.   Acta Crystallographica Section F-Structural Biology and Crystallization Communications

Treatment of Tuberculosis with Rifamycin-containing Regimens in Immune-deficient Mice

(2011) Ming Zhang et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Mycobacterial PE/PPE Proteins at the Host-Pathogen Interface

(2011) Samantha L. Sampson   Clinical & Developmental Immunology

Totally Drug-Resistant Tuberculosis in India

(2011) Z. F. Udwadia et al.   CLINICAL INFECTIOUS DISEASES

A new evolutionary and pharmacokinetic–pharmacodynamic scenario for rapid emergence of resistance to single and multiple anti-tuberculosis drugs

(2011) Jotam G Pasipanodya et al.   CURRENT OPINION IN PHARMACOLOGY

Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs

(2011) P. E. Almeida Da Silva et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

CD134 Plus CD137 Dual Costimulation Induces Eomesodermin in CD4 T Cells To Program Cytotoxic Th1 Differentiation

(2011) H. Z. Qui et al.   JOURNAL OF IMMUNOLOGY

Proteins with Complex Architecture as Potential Targets for Drug Design: A Case Study of Mycobacterium tuberculosis

(2011) Bálint Mészáros et al.   PLoS Computational Biology

Treatment of drug-resistant tuberculosis

(2011) Dick Menzies   Infection and Drug Resistance

Human Lung Immunity againstMycobacterium tuberculosis

(2010) Stephan Schwander et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Rv1218c, an ABC Transporter of Mycobacterium tuberculosis with Implications in Drug Discovery

(2010) M. Balganesh et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro and In Vivo Activities of LCB01-0371, a New Oxazolidinone

(2010) J.-W. Jeong et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Biomarker-Assisted Dose Selection for Safety and Efficacy in Early Development of PNU-100480 for Tuberculosis

(2010) Robert S. Wallis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Can immune parameters be used as predictors to distinguish between pulmonary multidrug-resistant and drug-sensitive tuberculosis?

(2010) Bayram Kiran et al.   Archives of Medical Science

Region of Difference 2 Contributes to Virulence ofMycobacterium tuberculosis

(2010) Robert A. Kozak et al.   INFECTION AND IMMUNITY

Understanding Latent Tuberculosis: A Moving Target

(2010) P. L. Lin et al.   JOURNAL OF IMMUNOLOGY

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis

(2010) Neel R Gandhi et al.   LANCET

Clinical Utility of a Commercial LAM-ELISA Assay for TB Diagnosis in HIV-Infected Patients Using Urine and Sputum Samples

(2010) Keertan Dheda et al.   PLoS One

The Antipsychotic Thioridazine Shows Promising Therapeutic Activity in a Mouse Model of Multidrug-Resistant Tuberculosis

(2010) Dick van Soolingen et al.   PLoS One

Epidemic Levels of Drug Resistant Tuberculosis (MDR and XDR-TB) in a High HIV Prevalence Setting in Khayelitsha, South Africa

(2010) Helen S. Cox et al.   PLoS One

Protein targets for structure-based anti-Mycobacterium tuberculosis drug discovery

(2010) Zhiyong Lou et al.   Protein & Cell

Cell-Mediated Immune Responses in Tuberculosis

(2009) Andrea M. Cooper   Annual Review of Immunology

Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli

(2009) Ali Akbar Velayati et al.   CHEST

Extensively drug-resistant tuberculosis

(2009) Philip LoBue   CURRENT OPINION IN INFECTIOUS DISEASES

Signaling mechanisms of the Mycobacterium tuberculosis receptor Ser/Thr protein kinases

(2009) Tom Alber   CURRENT OPINION IN STRUCTURAL BIOLOGY

Efflux-Mediated Drug Resistance in Bacteria

(2009) Xian-Zhi Li et al.   DRUGS

The Pks13/FadD32 Crosstalk for the Biosynthesis of Mycolic Acids inMycobacterium tuberculosis

(2009) Sabine Gavalda et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Unraveling the potential of intrinsically disordered proteins as drug targets: application to Mycobacterium tuberculosis

(2009) Meenakshi Anurag et al.   Molecular BioSystems

Synthetic EthR inhibitors boost antituberculous activity of ethionamide

(2009) Nicolas Willand et al.   NATURE MEDICINE

The spectrum of latent tuberculosis: rethinking the biology and intervention strategies

(2009) Clifton E. Barry et al.   NATURE REVIEWS MICROBIOLOGY

Drivers of tuberculosis epidemics: The role of risk factors and social determinants

(2009) Knut Lönnroth et al.   SOCIAL SCIENCE & MEDICINE

Inhibitors of FabI, an Enzyme Drug Target in the Bacterial Fatty Acid Biosynthesis Pathway

(2008) Hao Lu et al.   ACCOUNTS OF CHEMICAL RESEARCH

In Vitro Activities of Linezolid against Clinical Isolates of Mycobacterium tuberculosis Complex Isolated in Taiwan over 10 Years

(2008) T.-S. Huang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Alcohol use as a risk factor for tuberculosis – a systematic review

(2008) Knut Lönnroth et al.   BMC PUBLIC HEALTH

Cavitary Pulmonary Disease

(2008) L. B. Gadkowski et al.   CLINICAL MICROBIOLOGY REVIEWS

Crystal Structure of the Oxazolidinone Antibiotic Linezolid Bound to the 50S Ribosomal Subunit∥

(2008) Joseph A. Ippolito et al.   JOURNAL OF MEDICINAL CHEMISTRY